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Abstract
Airway epithelial cell responses are critical to the outcome of lung
infection. In this study, we aimed to identify unique contributions
of epithelial cells during lung infection. To differentiate genes
induced selectively in epithelial cells during pneumonia, we
compared genome-wide expression profiles from three sorted cell
populations: epithelial cells from uninfected mouse lungs,
epithelial cells from mouse lungs with pneumococcal pneumonia,
and nonepithelial cells from those same infected lungs. Of 1,166
transcripts that were more abundant in epithelial cells from
infected lungs compared with nonepithelial cells from the same
lungs or from epithelial cells of uninfected lungs, 32 genes were
identified as highly expressed secreted products. Especially strong
signals included two related secreted and transmembrane (Sectm)
1 genes, Sectm1a and Sectm1b. Refinement of sorting strategies
suggested that both Sectm1 products were induced predominantly
in conducting airway epithelial cells. Sectm1 was induced during
the early stages of pneumococcal pneumonia, and mutation of
NF-kB RelA in epithelial cells did not diminish its expression.
Instead, type I IFN signaling was necessary and sufficient for
Sectm1 induction in lung epithelial cells, mediated by signal
transducer and activator of transcription 1. For target cells,
Sectm1a bound to myeloid cells preferentially, in particular
Ly6GbrightCD11bbright neutrophils in the infected lung. In
contrast, Sectm1a did not bind to neutrophils from uninfected
lungs. Sectm1a increased expression of the neutrophil-attracting
chemokine CXCL2 by neutrophils from the infected lung. We
propose that Sectm1a is an epithelial product that sustains a
positive feedback loop amplifying neutrophilic inflammation
during pneumococcal pneumonia.
Keyword: pneumococcal pneumonia; lung epithelium; type I
IFNs; neutrophil activation; CXCL2
Clinical Relevance
Pneumonia results from failures of the host to respond
appropriately to microbes in the lung. The current studies
identify immune signaling roles that are unique to the epithelial
cells that line the surface of the lung.
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Lung infections are one of the most
prominent burdens of disease worldwide
(1). Despite the development of antibiotics
and vaccines, morbidity caused by
pneumonia is still considerable. Severe
pneumonias are difficult to treat and have a
high mortality rate due to lung injury (2).
They are responsible for the greatest number
of infectious disease deaths in the United
States (3). The bacteria causing pneumonia
most frequently is the pneumococcus,
Streptococcus pneumoniae (4, 5).
Epithelial cells constitute the entire
surface of the respiratory tract, and several
lines of evidence demonstrate that epithelial
cells have special roles during pneumonia
(6, 7). Interruptions of NF-kB and signal
transducer and activator of transcription
(STAT) 3 pathways in epithelial cells
exacerbate lung infection and lung
injury during pneumonia, implicating
transcriptional remodeling in these cells as a
critical determinant of tissue homeostasis
(8, 9). Pulmonary epithelial cells are
predominant sources of the cytokines,
CXCL5, granulocyte/macrophage
colony–stimulating factor (GM-CSF), and
CCL20, all of which are induced in an
NF-kB RelA–dependent mechanism
(10, 11). CXCL5 and GM-CSF promote
neutrophil recruitment during
pneumococcal pneumonia (11). A purpose
of the current study was to reveal additional
unique and essential immune roles that
epithelial cells perform during pneumonia.
Here, we introduce secreted and
transmembrane (Sectm) 1 protein induction
as a previously unrecognized, but
immunologically relevant epithelial response
to lung infection. Human Sectm1 and the
mouse orthologs, Sectm1a and Sectm1b, are
closely related Sectm proteins with a single
extracellular domain containing two regions
resembling Ig domains (12–14). Mouse
Sectm1a and Sectm1b genes are located
adjacent to one another on chromosome 11
and encode similar products (13, 14).
Sectm1 proteins appear to stimulate diverse
receptors, cells, and actions, but their
functions are still only beginning to be
defined. Sectm1 can serve as a costimulatory
ligand for T cell proliferation (14, 15) and as
a chemoattractant for monocytes (16). There
are multiple receptors, including CD7,
glucocorticoid-induced TNF receptor
(GITR), and additional ones yet to be
identified (13–17). To our knowledge,
Sectm1 proteins have not previously been
connected with pneumonia.
Materials and Methods
Mice
Experiments were performed using C57BL/6
mice, NK2 homeobox 1 (NKX2-1)-Cre Rela-
floxed mice (11), surfactant protein (SP) C
promoter–driven green fluorescent protein
(GFP) transgenic mice (18) (kindly provided
by John K. Heath, University of
Birmingham, Birmingham, UK), and IFN-
a/b receptor (IFNAR)-deficient mice (19).
The SPC-GFP and IFNAR colonies were
backcrossed at least eight generations onto
the C57BL/6 background. For RelA targeting
studies, all mice were homozygous for loxP
insertions in the Rela gene, and Cre-positive
mutants were compared with sex-matched
wild-type (WT) control littermates not
expressing Cre. For IFNAR-deficient mice,
homozygous mutants were compared
with sex-matched and age-matched
nonlittermate C57BL/6 controls that were
bred within the same mouse room as the
mutants. SPC-GFP mice were used to allow
comparisons of cell subsets and were not
compared with mice of other genotypes. The
age range throughout the studies was 7–19
weeks. All animal protocols were approved
by Boston University Institutional Animal
Care and Use Committee (Boston, MA) or
the University of California, Los Angeles (Los
Angeles, CA) Animal Research Committee.
Pneumonia
Mice were anesthetized by intraperitoneal
administration of ketamine (50 mg/kg)
and xylazine (5 mg/kg). An angiocatheter
was inserted into the left bronchus and
mice received intrabronchial delivery
of 50 ml saline containing 106 CFU of
S. pneumoniae serotype 19F EF3030 (11, 20).
In IFNAR-deficient mouse experiments,
mice were instilled with EF3030 into the
trachea, as previously described (19). The
EF3030 isolate of pneumococcus causes
a self-limiting and nonbacteremic
pneumonia in mice (8, 21, 22).
Sectm1a Binding Assay for Lung
Leukocytes
The binding of Sectm1a to leukocytes was
determined using flow cytometry (LSRII;
BD Biosciences, San Jose, CA), with
modification of methods previously
described (17, 23). Lungs of C57BL/6 mice
were perfused with 10 ml cold Hanks’
balanced salt solution (Life Technologies,
Waltham, MA) via the right ventricle
through the pulmonary artery. Perfused left
lungs were harvested and digested into
single-cell suspensions using collagenase
(Worthington, Lakewood, NJ) (24). The
lung cells were suspended in PBS and
incubated with vehicle, recombinant mouse
IgG2a Fc (stoichiometrically matched to
recombinant mouse Sectm1a-Fc), or
recombinant mouse Sectm1a-Fc chimera
protein (with Sectm1a fused to mouse
IgG2a Fc; R&D Systems, Minneapolis, MN)
for 1 hour on ice in the presence of purified
rat anti-mouse CD16/CD32 monoclonal
antibody (BD Pharmingen, San Jose, CA).
After incubation, cells were washed and
stained with phycoerythrin (PE)-
conjugated rat anti-mouse IgG2a (R&D
systems), followed by staining with multiple
surface marker antibodies consisting of
Pacific Blue–conjugated anti-mouse CD45,
FITC-conjugated anti-mouse Ly6g
lymphocyte antigen 6 complex, locus G
(Ly6G), PE/Cy7–conjugated anti-
mouse/human CD11b, and APC-
conjugated anti-mouse CD19 (Biolegend,
San Diego, CA) to differentiate leukocytes.
Dead cells were excluded using 7-
aminoactinomycin D (BD Pharmingen).
Statistical Analysis
Statistical analyses were performed using
GraphPad Prism (GraphPad Software
Inc., La Jolla, CA). Data are presented as
means (6SEM). Single-group comparisons
were done using Student’s t test. Multiple
group comparisons were made using either
a one-way or two-way ANOVA followed by
Sidak’s post hoc test.
Please see the online supplement for
descriptions of additional materials and
methods, including experimental reagent,
antibodies, lung epithelial cell sorting,
microarray analysis, gene set enrichment
analysis (GSEA), quantitative RT-PCR,
ELISA, Cell culture, STAT1 knockdown
by small interfering RNA, immunoblot,
Sectm1a binding assay for blood leukocytes,
and ex vivo neutrophil stimulation.
Results
Genes Induced Selectively in
Epithelial Cells during Pneumococcal
Pneumonia
We have previously developed digestion
and sorting strategies so that single-cell
suspensions from the mouse lung can be
separated into three distinct groups on
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the basis of relative expression of CD45
and CD326, also known as epithelial
cell adhesion molecule (EpCAM),
with epithelial cells identified as
CD452EpCAM1, leukocytes as CD451,
and other cell types being CD452EpCAM2
(11). To expand our understanding of
epithelial-specific roles in pneumonia, we
transcriptionally profiled sorted epithelial
and nonepithelial cells using microarray to
identify genes induced by pneumonia
selectively in epithelial cells. Mice were
instilled with pneumococcus, and left lungs
were collected 15 hours after infection.
Single-cell suspensions were generated and
sorted into two separate populations,
epithelial cells (CD452EpCAM1) and
others (all nonepithelial cells) (see Figure
E1 in the online supplement). We also
collected epithelial cells from the lungs of
uninfected mice. Genome-wide expression
profiling revealed 5,546 genes
differentially expressed (false discovery
rate [FDR] q, 0.05) in epithelial cells
from pneumonic lungs compared with
epithelial cells from uninfected lungs. To
begin dissecting molecular and
intercellular pathways that were
coordinately regulated in epithelial cells
due to pneumonia, we used GSEA to
analyze all gene changes observed in
epithelial cells due to pneumococcal
pneumonia (25). GSEA indicated 94 gene
sets being significantly coordinately up-
regulated (FDR q, 0.05), confirming
anticipated roles for some biological
pathways, such as NF-kB and implicating
diverse other pathways as well (Table 1
and Excel [Microsoft Corp., Redmond,
WA] spreadsheet in the online
supplement). After NF-kB, type I IFN
signaling was the second most highly
enriched gene set in epithelial cell
responses to pneumococcal pneumonia
(Table 1). Of the 5,546 genes induced by
infection in the epithelial cells, 1,166
genes were significantly (FDR q, 0.05)
more highly expressed in epithelial cells
compared with nonepithelial cells from
the same lungs (Figure 1A). The
expression patterns in Figure 1A
suggested that the majority of these genes
may be constitutive epithelial products
that were boosted by infection, as they
tended to appear higher in epithelial cells
from even noninfected lungs compared
with nonepithelial cells from infected
lungs. Approximately one-quarter of
these transcripts (326 genes, upper cluster
of Figure 1A) showed a different pattern,
perhaps reflecting little epithelial-specific
expression in the absence of infection, but
strong induction during pneumonia. To
interrogate our datasets for candidate
genes relevant to signaling from epithelial
cells to leukocytes, we filtered the 1,166
genes further to require a greater than
twofold change in both directions
(compared with uninfected epithelial cells
and with infected nonepithelial cells)
and used Database for Annotation,
Visualization and Integrated Discovery
(http://david.ncifcrf.gov) (26) to identify
those genes that were annotated as encoding
secreted proteins (SP_PIR_Secretion, FDR
q, 0.044), retrieving a list of 32 genes
(Figure 1B). The results confirmed
expectations from prior studies, returning
each of the three cytokines previously
identified as epithelial in origin during
pneumococcal pneumonia (CCL20,
CXCL5, and CSF2), and none of the
many cytokines previously identified as
having prominent nonepithelial sources
in the lung (such as CXCL1, CXCL2,
and CSF3) (11). The regulation and
function of the genes here identified as
induced selectively in epithelial cells are
of special interest. We chose to focus
our first studies on Sectm1 proteins,
because they are closely related and
poorly understood proteins that represent
two of the top seven signals in these
analyses.
Sectm1 Induction during
Pneumococcal Pneumonia
To verify that Sectm1 genes were indeed
induced during pneumococcal pneumonia,
we performed additional analyses of left-
lung mRNA throughout a time course of
infection. Both Sectm1a and Sectm1b
transcripts were induced (Figures 2A and
2B). Expression of each transcript peaked
1 day after infection, and thereafter
declined (Figures 2A and 2B). To
investigate Sectm1 induction in epithelial
cells specifically, mRNA was collected from
CD452EpCAM1 cells after 0, 9, or 24
hours of infection. In addition, results were
compared between WT mice and those
lacking functional RelA throughout the
pulmonary epithelium as an assessment of
potential activation mechanism. Sectm1a
Table 1. Gene Sets with Highest Enrichment of Up-Regulated Genes in Epithelial Cells
Group Gene Set Name NES
Reactome pathway ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS 2.50
Reactome pathway INTERFERON_ALPHA_BETA_SIGNALING 2.48
Reactome pathway INTERFERON_SIGNALING 2.46
Reactome pathway ER_PHAGOSOME_PATHWAY 2.45
KEGG pathway PROTEASOME 2.42
Reactome pathway AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1 2.39
Reactome pathway INTERFERON_GAMMA_SIGNALING 2.36
Reactome pathway CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX 2.36
Reactome pathway ANTIGEN_PROCESSING_CROSS_PRESENTATION 2.34
Reactome pathway VIF_MEDIATED_DEGRADATION_OF_APOBEC3G 2.33
Reactome pathway RP53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT 2.33
Reactome pathway CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM 2.33
Reactome pathway CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6 2.32
Reactome pathway DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 2.32
GO term INFLAMMATORY_RESPONSE 2.30
Definition of abbreviations: GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; NES, Normalized Enrichment Score.
NES indicates skewness of each gene set with respect to pneumonia. All gene sets listed above have a false discovery rate q, 0.001.
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and Sectm1b were equivalently induced in
sorted WT and RelA-deficient epithelial cells
(Figures 2C and 2D). This contrasts with the
three epithelial-specific cytokines that we
previously studied, CXCL5, CSF2 (GM-CSF),
and CCL20, all of which required NF-kB
RelA in epithelial cells (11), as measured in
the same samples here analyzed for Sectm1.
Thus, pneumococcal pneumonia can induce
Sectm1 transcription in epithelial cells by
mechanisms other than RelA.
Type I IFN Signaling Mediates Sectm1
Induction
To gain a first insight into potential
transcriptional signaling pathways that may
mediate RelA-independent expression of
Sectm1 in epithelial cells during pneumonia,
we used the Gene2Promoter and
Frameworker programs from the
Genomatix software suite (Munich,
Germany). In so doing, we identified
transcription factor binding site modules
that are present in the Sectm1a promoter
and are also significantly overrepresented
across the promoters of genes induced at
least 10-fold in epithelial cells during
pneumonia. The IFN regulatory factor
family, including binding sites for 12 related
transcription factors (IFN regulatory factors
1–9, Ring finger protein 31, Stat1, and
Stat2), was the most significant (P = 33
10212). This family of transcription factors
is activated by type I IFNs and by
cytoplasmic DNA sensing (27, 28), each of
which was independently identified by
GSEA as responses in epithelial cells during
pneumonia (Table 1 and Excel spreadsheet
in the online supplement). Using alveolar
epithelial cell–like E10 cells, we observed
that Sectm1a was induced by type I IFN
signaling (Figure 3A). Type I IFNs activate
multiple transcriptional regulatory
pathways, most, but not all, of which involve
STAT1 (29, 30). We used small interfering
RNA to effectively knock down STAT1 in
E10 cells (Figure 3B). Sectm1a induction by
IFN-b was significantly decreased by STAT1
knockdown (Figure 3C), demonstrating a
role for this specific transcription factor in
epithelial expression of Sectm1a. During
pneumococcal pneumonia, IFN-b was
expressed in the lungs at times relevant to
Sectm1 induction (Figure 3D). Signaling
from all type I IFNs, including multiple
IFN-a proteins as well as IFN-b, requires
a common IFNAR (29). We infected
IFNAR-deficient mice with pneumococcus
and quantified Sectm1 mRNA expression.
The induction of Sectm1a and Sectm1b by
pneumococcal pneumonia was significantly
diminished in mice lacking IFNAR (Figures
3E and 3F). Taken together, these data
suggest that Sectm1 induction during
pneumococcal pneumonia occurs in
epithelial cells specifically, and is induced by
type I IFN signaling through the IFNAR and
likely using the STAT1 transcription factor.
Conducting Airway Epithelial
Cell Sources of Sectm1 during
Pneumococcal Pneumonia
To discriminate Sectm1 expression among
different types of pulmonary epithelial
cells, we refined sorting strategies to
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Figure 1. Genes induced by pneumonia selectively in epithelial cells. (A) Heatmap of 1,166 genes with significantly higher expression in epithelial cells
from pneumonic lung compared with both other groups during pneumonia (false discovery rate [FDR] q, 0.05). Epi CTRL, epithelial cells from
uninfected mouse lungs; Epi PN, epithelial cells from pneumonic mouse lungs; Non-Epi PN, nonepithelial cells from pneumonic mouse lungs (n = 3 mice
per group, each column from an independent mouse). Red intensity represents the degree of higher level of expression, and blue intensity the degree
of lower level of expression. (B) To identify secreted proteins induced especially in epithelial cells owing to pneumonia, the genes with significant (FDR
q, 0.05) and strong (.twofold) up-regulation in epithelial cells from mice with pneumonia compared with both other groups (epithelial cells from
uninfected mice and nonepithelial cells from pneumonic mice) were probed using Database for Annotation, Visualization and Integrated Discovery
Bioinformatics. A total of 32 genes were identified as secreted proteins based on the SP_PIR_Secretion annotation. Expression of each transcript in
the indicated cell population is shown normalized to the relative expression of that transcript in epithelial cells sorted from uninfected mouse lungs.
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distinguish subsets of cells within the
CD452EpCAM1 population (Figure 4A).
The combination of EpCAM, T1a (also
known as podoplanin), and an SPC-
driven GFP transgene allowed us to
differentiate lung epithelial cell
populations into sets of GFPbright cells,
CD452GFP2EpCAM1T1abright cells, and
CD452GFP2EpCAM1T1a2 cells
(Figure 4A). Using mRNAs for SPC, caveolin-1,
and Forkhead box protein J1 (Foxj1) as
indicative of the presence of type II cells, type
I cells, and ciliated cells, respectively, we
conclude that these three cell populations
were effectively separated from each other
using this sorting strategy (Figure 4B). CC10,
a marker of club cells, was most abundantly
expressed in CD452GFP2EpCAM1T1a2
cells, where the ciliated cells were also found,
but was also expressed in both GFPbright cells
and CD452GFP2EpCAM1T1abright cells
(Figure 4B). This may be because club
cells get collected in multiple sorted cell
populations. Alternatively, this may result
from cells other than club cells expressing
CC10, such as cells expressing both CC10
and SPC that exist in bronchoalveolar
duct junctions or alveolar regions
(31–33). We measured Sectm1 transcripts
across these four sorted cell populations,
which revealed that Sectm1 transcripts
were predominantly induced in the
CD452GFP2EpCAM1T1a2 group
containing both types of conducting
airway epithelial cells (ciliated cells
and club cells), but neither type I
nor type II alveolar epithelial cells
(Figure 4C). Induction was observed in the
CD452GFP2EpCAM1T1abright cells as
well, consistent with expression by type I
cells, but this was modest in comparison
to the CD452GFP2EpCAM1T1a2 cells
(Figure 4C). Therefore, we conclude that
conducting airway epithelial cells are
predominant sites of Sectm1 induction
during pneumococcal pneumonia.
Sectm1a Interacts with Myeloid Cells
in the Pneumonic Lung
In an effort to identify cells potentially
responsive to Sectm1a, we investigated
cell-specific binding capacity. Lacking an
antibody that recognized mouse Sectm1a, a
recombinant Sectm1a-Fc fusion protein was
used to identify Sectm1a-binding cells with
flow cytometry. The Fc portion from mouse
IgG2a, attached to mouse Sectm1a, was
detected using a secondary PE-conjugated
anti-mouse IgG2a antibody. By applying
this method to single-cell suspensions
from lungs of mice with pneumococcal
pneumonia, we found that Sectm1a mainly
interacts with myeloid cells, including both
Ly6G-positive cells, considered to be
neutrophils, and Ly6G-negative cells that
likely included monocytes, macrophages,
and dendritic cells (Figure 5A). The
negative control, recombinant murine Fc
protein without the Sectm1a fusion,
consistently failed to bind these cells
(Figure 5). To determine the binding of
Sectm1a to lymphocytes more precisely,
we differentiated T cells (CD451CD31),
NK cells (CD451CD32NK1.11), and
B cells (CD451CD191) individually in
independent experiments (Figure E2A),
and found that Sectm1a could bind to T
and NK cells (Figures E2B–E2D), but only
a small fraction compared with myeloid cell
binding. Intriguingly, the Sectm1a appeared
to preferentially bind to the neutrophils
that were brightest for Ly6G and CD11b in
the pneumonic lung (Figure 5B), and
neutrophils from uninfected lungs did not
bind Sectm1a (Figure 5C). Furthermore,
circulating blood neutrophils collected
from either uninfected or infected mice also
failed to bind Sectm1a (data not shown
and Figure 5D). These data suggest that
neutrophils become activated in the lung
during pneumonia, and consequently
acquire the ability to bind Sectm1a.
Altogether, these data suggest that Sectm1a
is elaborated by epithelial cells in the
infected lung and interacts with highly
activated neutrophils recruited there.
Sectm1a Promotes CXCL2
Production by Neutrophils from the
Pneumonic Lung
Based on preferential binding of Sectm1a
to neutrophils from infected, but not
uninfected, lungs, we endeavored to test the
immunological influence of Sectm1a on
highly activated neutrophils. We collected
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Figure 2. Pneumonia can induce secreted and transmembrane (Sectm) 1 transcription in
epithelial cells by mechanisms other than RelA. (A and B) C57BL/6 mice were infected with
Streptococcus pneumoniae serotype 19F. mRNAs were measured in left-lung homogenates
using quantitative RT-PCR (qRT-PCR) at indicated time points. Values represent fold induction
relative to 0 hours and were expressed as means (6SEM). Significance was determined by one-
way ANOVA with Sidak’s post hoc test (n = 4–8 per group). *P, 0.05 versus 0 hours. (C and D)
NK2 homeobox 1–Cre Rela-floxed mice in which RelA was mutated throughout the lung
epithelium, or wild-type (WT) control littermates with no Cre expression, were infected with
pneumococcus and killed 9 or 24 hours after infection, after which left-lung epithelial cells,
identified as CD452EpCAM1, were isolated by FACS. Values represent fold induction relative to
epithelial cells isolated from 0-hour Cre-negative mice and were expressed as mean (6SEM).
Significance was determined by two-way ANOVA with Sidak’s post hoc test (n = 3–4 per group).
*P, 0.05 versus 0 hour.
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neutrophils from bronchoalveolar lavage
(BAL) fluids of infected mice 20 hours after
infection. BAL neutrophils were cultured
with Sectm1a-Fc or negative controls
(recombinant mouse Fc or vehicle).
Transcript levels were measured by
quantitative RT-PCR for cytokines
including CXCL1, CXCL2, TNF-a, IL1-b,
and CXCL10. Sectm1a significantly
increased expression of CXCL2 and TNF-a,
but not the other cytokines measured
(Figures 6A–6E). CXCL2 protein levels
were consistent with the mRNA data,
indicating a significant increase in CXCL2
protein, but not in TNF-a protein from
BAL neutrophils stimulated with Sectm1a
(Figures 6F and 6G). Surface markers
associated with neutrophil activation,
including CD11b, CD18, and CD62L, were
not further altered by Sectm1a stimulation
(Figures 6H–6J). Collectively, these data
suggest that epithelial-derived Sectm1a
engages neutrophils to promote the
expression and release of proinflammatory
mediators, including CXCL2.
In Vivo Effect of Recombinant
Sectm1a-Fc on Pneumococcal
Pneumonia
In addition to ex vivo experiments, we
examined the in vivo effect of exogenous
Sectm1a on recruitment of leukocytes into
the airspace and bacterial clearance during
pneumococcal pneumonia. Sectm1a-Fc or
negative controls (recombinant mouse
Fc or vehicle) were coinstilled with
pneumococcus. Sectm1a did not
significantly change these outcomes
compared with negative control groups
(Table 2). These results suggest that the
amount Sectm1 expressed during
pneumonia was not present in limiting
concentrations, that the timing of
exogenous Sectm1 administration (with the
initial bacterial infection, before any
neutrophil recruitment) may be inadequate
for observing Sectm1 activities, that Sectm1
might not contribute to the outcomes
measured, or that the outcomes of interest
may have already been at maximal levels.
Discussion
In this study, we sought to identify
epithelial-specific immunomodulators
during pneumonia. Our genome-wide
expression profiling revealed that more than
5,000 genes are differentially expressed in
epithelial cells after infection, indicating that
these cells undergo diverse and considerable
transcriptional remodeling during
pneumococcal pneumonia. We have
extensively studied the role of NF-kB RelA
in pulmonary epithelial cells (8, 10, 11),
and NF-kB was prominently reflected in
these transcriptional responses of epithelial
cells. In addition, GSEA identified IFN
signaling, particularly from type I IFNs
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Figure 3. Type I IFN signaling mediates Sectm1 induction through signal transducer and activator of
transcription (STAT) 1. (A) Alveolar epithelial cell–like E10 cells were stimulated with IFN-b (1,000 U/ml)
for 6 hours. Expression of Sectm1a was measured using qRT-PCR. Values represent fold induction
relative to vehicle group and were expressed as means (6SEM). Significance was determined by
Student’s t test. Results reflect data from three independent experiments. *P, 0.05 versus vehicle.
(B) Immunoblot analysis of E10 cells 48 hours after transfection with either nontargeting (NT) or STAT1
small interfering RNA (siRNA). (C) qRT-PCR of Sectm1a expression in siRNA transfected cells treated
with vehicle or IFN-b (1,000 U/ml) for 6 hours. Values represent fold induction compared with
nontargeting and vehicle-treated group and were expressed as means (6SEM). Significance was
determined by two-way ANOVA with Sidak’s post hoc test. Results reflect data from three
independent experiments. *P, 0.05 versus nontargeting siRNA. (D) C57BL/6 mice were infected
with S. pneumoniae serotype 19F. Expressions of IFN-b were measured in left-lung homogenates
using qRT-PCR at indicated time points. Values represent fold induction relative to 0 hours and are
expressed as means (6SEM). Significance was determined by one-way ANOVA with Sidak’s
post hoc test (n = 4–8 per group). *P, 0.05 versus 0 hour. (E and F ) WT and IFN-a/b receptor
(IFNAR)-deficient mice were infected with S. pneumoniae serotype 19F and killed 24 hours after
infection. mRNAs were measured in lung homogenates using qRT-PCR. Values represent fold induction
relative to 0 hour, WT, and are expressed as means (6SEM). Significance was determined by two-way
ANOVA with Sidak’s post hoc test (n= 4–5 in each experimental group). *P, 0.05 versus WT.
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(IFN-a and -b), as the next most up-
regulated gene set in epithelial cells due to
pneumococcal pneumonia. A fourth of
the genes induced in epithelial cells were
expressed at higher levels compared with
other cells from the same infected lungs. A
limitation inherent to these analyses is that
the pool of all nonepithelial cells was
compared with the epithelial cells. It is
conceivable that a subset within the
nonepithelial cell population (such as
neutrophils alone or smooth muscle cells
alone) may have a signal that is diluted
by the RNA from other cell types not
expressing that gene, and hence expression
by subsets of nonepithelial cells may be
underestimated. Another limitation is that
only lung cells were examined, and some
of these genes may also be expressed by
cells outside of the lungs. For instance,
orosomucoids (ORMs; ORM1, ORM2,
ORM3), also known a1-acid glycoproteins,
are immunomodulatory proteins (34, 35)
that were some of the most highly induced
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Figure 4. Conducting airway epithelial cells produce Sectm1 during pneumonia. (A and B) Surfactant protein (SP) C–green fluorescent protein (GFP) transgenic
mice were infected with S. pneumoniae serotype 19F. Left lungs were harvested 24 hours after infection and digested to single-cell suspensions with elastase.
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Values represent fold induction relative to CD451 cells and are expressed as means (6SEM). Significance was determined by one-way ANOVA with
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Figure 5. Sectm1a interacts with myeloid cells in the pneumonic lung. (A) C57BL/6 mice were infected with S. pneumoniae serotype 19F, and left lungs
were harvested 24 hours after infection. Single-cell suspensions from collagenase-digested left lung were incubated with vehicle (data not shown),
recombinant Fc (25 mg/ml, stoichiometrically matched to recombinant mouse Sectm1a-Fc), or recombinant Sectm1a-Fc (40 mg/ml). The cells were
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antibodies. Binding of Sectm1a to cells was detected as PE signal. Results are representative of three independent experiments. Gates were determined
based on cells incubated with vehicle (data not shown). (B) Neutrophils (CD451Ly6G1) of the pneumonic lungs were further divided into two
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histograms reflect those incubated with Fc or Sectm1a-Fc, respectively. (C) Uninfected lungs were harvested and Sectm1a binding assay was performed
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epithelial-specific products in the infected
lung in the present studies. ORMs are better
known as acute-phase proteins that are
synthesized by hepatocytes in the liver,
including during pneumococcal pneumonia
(36). Although ORMs and other proteins
may be induced outside the lungs also, we
interpret these data as suggesting that local
expression within the lung is epithelial cell
predominant for several hundred genes.
The set of 32 genes that we identified as
pneumococcal pneumonia–induced
Figure 5. (Continued). using the same doses of Fc (25 mg/ml) and Sectm1a-Fc (40 mg/ml) as in (A) to determine the binding of Sectm1a-Fc to neutrophils
(CD451Ly6G1). Gates were determined based on vehicle group (data not shown). Results are representative of three independent experiments. (D) Blood was
collected 20 hours after intrabronchial instillation of S. pneumoniae serotype 19F. Sectm1a binding assay was performed using the same doses of Fc (25 mg/ml)
and Sectm1a-Fc (40 mg/ml) to determine the binding of Sectm1a-Fc to blood neutrophils (CD451Ly6G1). Gates were determined based on vehicle group (data
not shown). Results are representative of three independent experiments. Ly6G, Ly6g lymphocyte antigen 6 complex, locus G; rm, recombinant murine.
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Figure 6. Sectm1a promotes chemokine (C-X-C) motif ligand (CXCL) 2 production by neutrophils from the pneumonic lung. C57BL/6 mice were infected
with S. pneumoniae serotype 19F, and bronchoalveolar lavage fluid was collected 20 hours after infection, from which neutrophils were isolated. Isolated
neutrophils were cultured and stimulated with vehicle, Fc (39 mg/ml, stoichiometrically matched to recombinant mouse Sectm1a-Fc), or Sectm1a-Fc
(60 mg/ml) for 2 hours (A–E), 8 hours (F and G), or 4 hours (H–J). (A–E) qRT-PCR was performed on total cellular RNA to determine the gene expressions of
CXCL1, CXCL2, TNF-a, IL1-b, and CXCL10. Values represent fold induction relative to vehicle group and were expressed as means (6SEM). Significance
was determined by one-way ANOVA with Sidak’s post hoc test (n = 9 per group). *P, 0.05 versus vehicle. (F and G) CXCL2 and TNF-a levels were
measured by ELISA from culture supernatants of neutrophils. Values represent fold induction relative to vehicle and were expressed as means (6SEM).
Significance was determined by one-way ANOVA with Sidak’s post hoc test (n = 9 per group). *P, 0.05 versus vehicle. (H–J) After stimulation, neutrophils
were washed and stained with anti-mouse CD45, Ly6G, CD11b, CD18, and CD62L antibodies. The expression of surface markers, including CD11b,
CD18, and CD62L, was determined in each group using flow cytometry. Cells represented in red, blue, or orange histograms reflect those stimulated with
vehicle, Fc, or Sectm1a-Fc, respectively. Results are representative of four samples.
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secreted products from epithelial cells likely
represents an underestimation. However,
perfect matching, to our knowledge base of
whether cytokines derive from epithelial or
nonepithelial cells during pneumococcal
pneumonia (11), provides confidence in
ascribing these as epithelial-specific
secreted proteins. We selected the Sectm1
proteins as deserving of further study,
because they were such prominent signals
and are so poorly understood, but other
genes identified in Figure 1B as
pneumococcal pneumonia–induced
secreted products from epithelial cells
demand further investigation as potential
regulators of lung immunity.
To our knowledge, this is the first study
to report connections of Sectm1 with
pulmonary infection. There is limited prior
knowledge about Sectm1 and disease, other
than an association with melanoma (16).
During pneumococcal pneumonia, Sectm1
transcripts were induced during early stages
of amplifying inflammation. Mouse
Sectm1a and Sectm1b were reported to
be similar proteins in terms of their
chromosomal location and amino acid
sequences (13, 14). Here, we find that they
are similarly regulated in the inflamed lung.
Sectm1 transcripts were induced by a RelA-
independent mechanism, which was
unexpected. NF-kB RelA is a central
transcription factor that regulates many
inflammatory and immune-modulatory
reactions during acute bacterial infection
(8, 37). All three cytokines previously
identified as epithelial cell derived during
pneumonia (CCL20, CXCL5, and GM-CSF)
require NF-kB RelA for their induction
(11). In contrast to these, our data suggest
that induction of both Sectm1a and
Sectm1b is stimulated by type I IFNs and
mediated by IFNAR and STAT1.
Type I IFNs likely have multiple
influences on host defense against bacterial
infection (38), with functions that are more
complex and heterogeneous than those
observed in the setting of viral infection
(38, 39). In postinfluenza pneumococcal
pneumonia, type I IFNs are deleterious for
impairing production of neutrophil
chemoattractants, including CXCL1 and
CXCL2 (19). On the other hand, in primary
pneumococcal pneumonia, type I IFNs can
enhance host defense, decrease bacterial
burdens in the lungs and blood, and
improve survival rates (40, 41). Differential
roles of type I IFNs during pneumococcal
pneumonia may vary according to
characteristics of the host (including
genetic and environmental variations in
immune pathways) and the microbe
(including virulence factors), and demand
further investigation. Sectm1 is induced
by type I IFNs during pneumococcal
pneumonia, and may contribute to some of
the phenotypes mediated by IFNAR
signaling.
The current results indicate that type I
IFNs contribute to Sectm1 expression.
However, these are probably not the only
inflammatory mediators driving Sectm1
expression during pneumonia. Both
Sectm1a and Sectm1b were significantly
reduced in IFNAR-deficient mice with
pneumococcal pneumonia, but some
residual induction of each remained. It has
been reported that human Sectm1 can be
induced by IFN-g (15), and IFN-g is
increased in the lung during S. pneumoniae
infection (42); thus, IFN-g may be an
additional contributor to Sectm1 induction
in the lungs. We observed here that Sectm1
induction by IFN-b is mediated by the
STAT1 transcription factor, which also
mediates signaling from IFN-g (29), so
other STAT1-activating cytokines that are
expressed during pneumonia may be
additional activators of Sectm1 in the
infected lung. The STAT1 knockdown was
performed in E10 cells, which resemble
type I alveolar epithelial cells, so asserting
that STAT1 mediates induction in
columnar epithelial cells and in the lungs is
based on extrapolation. Roles of IFNAR
were determined in whole lungs in vivo.
The present data suggest that the majority,
but not all, of the Sectm1 induced during
pneumonia depends on type I IFN
signaling through IFNAR.
Our results indicate that Sectm1a
exhibits greater binding to myeloid cells
than to lymphocytes. Prior reports identified
an interaction between Sectm1 and T cells or
NK cells (13–15), which was detectable with
such cells from the pneumonic lung, but
only with a modest signal. In in vitro
studies, human Sectm1 and mouse Sectm1a
costimulate T cells, inducing their
proliferation as well as cytokine production
(14, 15), and human Sectm1 increases
expression of activation markers of NK
cells, such as CD69 (13). Our results do not
disagree with the prior studies of Sectm1
interactions with lymphocytes, as our assay
system (relying on stable binding of
recombinant tagged Sectm1 to the cell
surface, followed by detection of the
recombinant fusion protein with a
fluorescent anti-tag antibody) was very
different from assays in prior studies. For
example, this seeming disparity may be
explained if Sectm1 interacts with receptors
on neutrophil surfaces with greater avidity
than with the receptors on T cell or NKT
cell surfaces. To the best of our knowledge,
this is the first report that Sectm1a binds
to neutrophils, and, using this assay, this
interaction was more prominent than its
binding to lymphocytes. Interestingly, it
appears that Sectm1a preferentially binds to
subsets of neutrophils. Sectm1a does not
bind to neutrophils from uninfected lungs
or from the blood of either infected or
uninfected mice, but it does bind to some of
Table 2. In Vivo Effect of Recombinant Murine Secreted and Transmembrane 1a–Fc on
Pneumococcal Pneumonia
Vehicle rm Fc rm Sectm1a-Fc
Cell counts (3106) in BALF from
pneumonic lung
Total cells 1.576 0.03 1.126 0.19 1.416 0.20
Macrophages and monocytes 0.336 0.02 0.286 0.02 0.366 0.04
Neutrophils 1.246 0.04 0.846 0.16 1.066 0.17
CFU (3106) in pneumonic lung 1.176 1.12 0.206 0.16 0.526 0.32
Definition of abbreviations: BALF, bronchoalveolar lavage fluid; rm, recombinant murine; Sectm1a,
secreted and transmembrane 1a.
C57BL/6 mice were coinstilled with vehicle, rm Fc (50 mg/ml), or rm Sectm1a-Fc (80 mg/ml) into left
lungs in addition to Streptococcus pneumoniae serotype 19F. BALF was collected 20 hours after
coinstillation, and total and differential cell counts were determined. Bilateral lungs were harvested at
24 hours after coinstillation, and bacterial burden was measured in whole-lung homogenates using
CFU analysis. There were no statistically significant differences among three experimental groups in
both experiments. Values are expressed as means (6SEM). Significance was determined by one-way
ANOVA with Sidak’s post hoc test (n = 3–8 per group and 6–7 per group, respectively).
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the neutrophils within pneumonic lungs,
notably those with the greatest expression
of both CD11b and Ly6G. Although
neutrophils are defined by common
elements (such as their distinctive-shaped
nucleus and their characteristic granules), it
is becoming increasingly clear that this is
a remarkably heterogeneous population of
cells, even at a healthy baseline (43).
Changes in neutrophils during the
maturation stages combined with their
brief lifespans add to this complexity.
Furthermore, acute and chronic
inflammatory stimuli additionally alter
neutrophil phenotypes. Generally, surface
levels of CD11b and of Ly6G are increased
in the most mature neutrophils and with
activation by proinflammatory stimuli
(43–46). The facts that Sectm1a binds to
CD11bbrightLy6Gbright neutrophils from an
inflammatory site, but not neutrophils from
other sites or times, suggest to us that
neutrophils must be both mature and
activated to interact with this ligand. The
neutrophil receptor(s) for Sectm1a are
unknown. Human and mouse Sectm1
proteins interact with T cells via multiple
receptors, including CD7 and GITR, but
other Sectm1 receptors on T cells are
implicated as well, and are yet to be
identified (13, 14). We find that neutrophils
collected from infected mouse lungs express
vanishingly low levels of CD7 and GITR,
far less than mouse T cells (data not shown),
making these unlikely candidates for Sectm1
receptors on activated neutrophils.
How Sectm1 alters immune and
inflammatory processes within the lung is
now proposed as an important new
question, which only begins to be addressed
here. Sectm1a enhanced CXCL2 production
by neutrophils from the pneumonic lung.
CXCL2 is a potent inducer of neutrophil
chemotaxis (47), and it plays critical roles
in neutrophil recruitment during lung
infections (48, 49). Neutrophil-derived
CXCL2 is central to a positive-feedback
loop for neutrophil recruitment in the
infected lung (50). Taken together, these
data suggest that epithelial-derived Sectm1a
is proinflammatory by amplifying a
neutrophil-driven positive-feedback loop in
the pneumonic lung. If Sectm1 is most
highly expressed by columnar epithelial
cells, such as club cells or ciliated cells, then
this effect on neutrophil recruitment may
be most prominent in the conducting
airways. However, a major limitation of this
study is the inability to inhibit Sectm1
function in vivo, due to the absence of
effective tools at present. To our knowledge,
reports of mice deficient in Sectm1a and/or
Sectm1b have yet to be published, nor have
reports of blocking antibodies against
mouse Sectm1a and/or Sectm1b. Future
studies in which Sectm1a and Sectm1b can
be interrupted in vivo, independently as
well as concurrently, will be essential to
assessing the full significance of this newly
recognized pathway in lung immunity.
In conclusion, a genome-wide
approach demonstrates that expression
of many genes is altered in the epithelium
in response to pneumococcal infection,
which involves diverse pathways,
including some that had not previously
been implicated in pneumonia. Sectm1a is
a largely uncharacterized epithelial
product that is induced by type I IFNs,
mediated by STAT1. Sectm1a interacts
with neutrophils in the pneumonic lung,
enhancing their production of CXCL2,
which we propose feeds into a positive-
feedback loop amplifying neutrophilic
inflammation. The full functional
significance of Sectm1a in pneumococcal
pneumonia is an important focus for
further studies. n
Author disclosures are available with the text
of this article at www.atsjournals.org.
Acknowledgments: The authors thank Patrick
Autissier (Flow Cytometry Core Facility, Boston
University School of Medicine, Boston, MA) for
outstanding technical help with these studies.
References
1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M,
Shibuya K, Salomon JA, Abdalla S, Aboyans V, et al. Years lived with
disability (YLDs) for 1160 sequelae of 289 diseases and injuries
1990–2010: a systematic analysis for the Global Burden of Disease
Study 2010. Lancet 2012;380:2163–2196.
2. Bauer TT, Ewig S, Rodloff AC, Mu¨ller EE. Acute respiratory distress
syndrome and pneumonia: a comprehensive review of clinical data.
Clin Infect Dis 2006;43:748–756.
3. Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease
mortality in the United States during the 20th century. JAMA 1999;
281:61–66.
4. van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of
pneumococcal pneumonia. Lancet 2009;374:1543–1556.
5. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM,
Reed C, Grijalva CG, Anderson EJ, Courtney DM, et al.; CDC EPIC
Study Team. Community-acquired pneumonia requiring
hospitalization among U.S. adults. N Engl J Med 2015;373:415–427.
6. Cleaver JO, You D, Michaud DR, Pruneda FA, Juarez MM, Zhang J,
Weill PM, Adachi R, Gong L, Moghaddam SJ, et al. Lung epithelial
cells are essential effectors of inducible resistance to pneumonia.
Mucosal Immunol 2014;7:78–88.
7. Parker D, Prince A. Innate immunity in the respiratory epithelium. Am J
Respir Cell Mol Biol 2011;45:189–201.
8. Quinton LJ, Jones MR, Simms BT, Kogan MS, Robson BE, Skerrett SJ,
Mizgerd JP. Functions and regulation of NF-kB RelA during
pneumococcal pneumonia. J Immunol 2007;178:1896–1903.
9. Quinton LJ, Jones MR, Robson BE, Simms BT, Whitsett JA, Mizgerd JP.
Alveolar epithelial STAT3, IL-6 family cytokines, and host defense
during Escherichia coli pneumonia. Am J Respir Cell Mol Biol 2008;38:
699–706.
10. Yamamoto K, Ferrari JD, Cao Y, Ramirez MI, Jones MR, Quinton LJ,
Mizgerd JP. Type I alveolar epithelial cells mount innate immune
responses during pneumococcal pneumonia. J Immunol 2012;189:
2450–2459.
11. Yamamoto K, Ahyi AN, Pepper-Cunningham ZA, Ferrari JD, Wilson AA,
Jones MR, Quinton LJ, Mizgerd JP. Roles of lung epithelium in
neutrophil recruitment during pneumococcal pneumonia. Am J
Respir Cell Mol Biol 2014;50:253–262.
12. Slentz-Kesler KA, Hale LP, Kaufman RE. Identification and
characterization of K12 (SECTM1), a novel human gene that encodes
a Golgi-associated protein with transmembrane and secreted
isoforms. Genomics 1998;47:327–340.
13. Lyman SD, Escobar S, Rousseau AM, Armstrong A, Fanslow WC.
Identification of CD7 as a cognate of the human K12 (SECTM1)
protein. J Biol Chem 2000;275:3431–3437.
14. Howie D, Garcia Rueda H, Brown MH, Waldmann H. Secreted and
transmembrane 1A is a novel co-stimulatory ligand. PLoS One 2013;
8:e73610.
15. Wang T, Huang C, Lopez-Coral A, Slentz-Kesler KA, Xiao M,
Wherry EJ, Kaufman RE. K12/SECTM1, an interferon-g regulated
molecule, synergizes with CD28 to costimulate human T cell
proliferation. J Leukoc Biol 2012;91:449–459.
16. Wang T, Ge Y, Xiao M, Lopez-Coral A, Li L, Roesch A, Huang C,
Alexander P, Vogt T, Xu X, et al. SECTM1 produced by tumor cells
attracts human monocytes via CD7-mediated activation of the PI3K
pathway. J Invest Dermatol 2014;134:1108–1118.
ORIGINAL RESEARCH
Kamata, Yamamoto, Wasserman, et al.: Sectm1 Signaling in the Infected Lung 417
17. Bade-Doding C, Gottmann W, Baigger A, Farren M, Lee KP, Blasczyk R,
Huyton T. Autocrine GM-CSF transcription in the leukemic progenitor
cell line KG1a is mediated by the transcription factor ETS1 and is
negatively regulated through SECTM1 mediated ligation of CD7.
Biochim Biophys Acta 2014;1840:1004–1013.
18. Lo B, Hansen S, Evans K, Heath JK, Wright JR. Alveolar epithelial type
II cells induce T cell tolerance to specific antigen. J Immunol 2008;
180:881–888.
19. Shahangian A, Chow EK, Tian X, Kang JR, Ghaffari A, Liu SY,
Belperio JA, Cheng G, Deng JC. Type I IFNs mediate development
of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009;
119:1910–1920.
20. Francis KP, Yu J, Bellinger-Kawahara C, Joh D, Hawkinson MJ, Xiao G,
Purchio TF, Caparon MG, Lipsitch M, Contag PR. Visualizing
pneumococcal infections in the lungs of live mice using
bioluminescent Streptococcus pneumoniae transformed with a novel
gram-positive lux transposon. Infect Immun 2001;69:3350–3358.
21. Jones MR, Quinton LJ, Simms BT, Lupa MM, Kogan MS, Mizgerd JP.
Roles of interleukin-6 in activation of STAT proteins and recruitment
of neutrophils during Escherichia coli pneumonia. J Infect Dis 2006;
193:360–369.
22. Briles DE, Hollingshead SK, Paton JC, Ades EW, Novak L, van Ginkel FW,
Benjamin WH Jr. Immunizations with pneumococcal surface protein A
and pneumolysin are protective against pneumonia in a murine model
of pulmonary infection with Streptococcus pneumoniae. J Infect Dis
2003;188:339–348.
23. Lefort CT, Rossaint J, Moser M, Petrich BG, Zarbock A, Monkley SJ,
Critchley DR, Ginsberg MH, Fa¨ssler R, Ley K. Distinct roles for talin-1
and kindlin-3 in LFA-1 extension and affinity regulation. Blood 2012;
119:4275–4282.
24. Sauer KA, Scholtes P, Karwot R, Finotto S. Isolation of CD41 T cells
from murine lungs: a method to analyze ongoing immune responses
in the lung. Nat Protoc 2006;1:2870–2875.
25. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL,
Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al.
Gene set enrichment analysis: a knowledge-based approach for
interpreting genome-wide expression profiles. Proc Natl Acad Sci
USA 2005;102:15545–15550.
26. Huang W, Sherman BT, Lempicki RA. Systematic and integrative
analysis of large gene lists using DAVID bioinformatics resources.
Nat Protoc 2009;4:44–57.
27. Tamura T, Yanai H, Savitsky D, Taniguchi T. The IRF family
transcription factors in immunity and oncogenesis. Annu Rev
Immunol 2008;26:535–584.
28. Kawai T, Akira S. Toll-like receptors and their crosstalk with other
innate receptors in infection and immunity. Immunity 2011;34:
637–650.
29. Decker T, Mu¨ller M, Stockinger S. The yin and yang of type I interferon
activity in bacterial infection. Nat Rev Immunol 2005;5:675–687.
30. Ivashkiv LB, Donlin LT. Regulation of type I interferon responses.
Nat Rev Immunol 2014;14:36–49.
31. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S,
Crowley D, Bronson RT, Jacks T. Identification of bronchioalveolar
stem cells in normal lung and lung cancer. Cell 2005;121:823–835.
32. Rock JR, Gao X, Xue Y, Randell SH, Kong YY, Hogan BL. Notch-
dependent differentiation of adult airway basal stem cells. Cell Stem
Cell 2011;8:639–648.
33. Kotton DN, Morrisey EE. Lung regeneration: mechanisms, applications
and emerging stem cell populations. Nat Med 2014;20:822–832.
34. Lee YS, Choi JW, Hwang I, Lee JW, Lee JH, Kim AY, Huh JY, Koh YJ,
Koh GY, Son HJ, et al. Adipocytokine orosomucoid integrates
inflammatory and metabolic signals to preserve energy homeostasis
by resolving immoderate inflammation. J Biol Chem 2010;285:
22174–22185.
35. Hochepied T, Berger FG, Baumann H, Libert C. Alpha1-acid glycoprotein:
an acute phase protein with inflammatory and immunomodulating
properties. Cytokine Growth Factor Rev 2003;14:25–34.
36. Quinton LJ, Blahna MT, Jones MR, Allen E, Ferrari JD, Hilliard KL,
Zhang X, Sabharwal V, Algu¨l H, Akira S, et al. Hepatocyte-specific
mutation of both NF-kB RelA and STAT3 abrogates the acute phase
response in mice. J Clin Invest 2012;122:1758–1763.
37. Mizgerd JP. Acute lower respiratory tract infection. N Engl J Med 2008;
358:716–727.
38. Carrero JA. Confounding roles for type I interferons during bacterial and
viral pathogenesis. Int Immunol 2013;25:663–669.
39. Trinchieri G. Type I interferon: friend or foe? J Exp Med 2010;207:
2053–2063.
40. LeMessurier KS, Ha¨cker H, Chi L, Tuomanen E, Redecke V. Type I
interferon protects against pneumococcal invasive disease by
inhibiting bacterial transmigration across the lung. PLoS Pathog
2013;9:e1003727.
41. Damjanovic D, Khera A, Medina MF, Ennis J, Turner JD, Gauldie J,
Xing Z. Type 1 interferon gene transfer enhances host defense
against pulmonary Streptococcus pneumoniae infection via
activating innate leukocytes. Mol Ther Methods Clin Dev 2014;1:5.
42. Yamada M, Gomez JC, Chugh PE, Lowell CA, Dinauer MC, Dittmer DP,
Doerschuk CM. Interferon-g production by neutrophils during
bacterial pneumonia in mice. Am J Respir Crit Care Med 2011;183:
1391–1401.
43. Becher B, Schlitzer A, Chen J, Mair F, Sumatoh HR, Teng KW, Low D,
Ruedl C, Riccardi-Castagnoli P, Poidinger M, et al. High-dimensional
analysis of the murine myeloid cell system. Nat Immunol 2014;15:
1181–1189.
44. Yong KL, Rowles PM, Patterson KG, Linch DC. Granulocyte-
macrophage colony–stimulating factor induces neutrophil adhesion
to pulmonary vascular endothelium in vivo: role of b2 integrins.
Blood 1992;80:1565–1575.
45. Satake S, Hirai H, Hayashi Y, Shime N, Tamura A, Yao H, Yoshioka S,
Miura Y, Inaba T, Fujita N, et al. C/EBPb is involved in the
amplification of early granulocyte precursors during candidemia-
induced “emergency” granulopoiesis. J Immunol 2012;189:
4546–4555.
46. Lee PY, Wang JX, Parisini E, Dascher CC, Nigrovic PA. Ly6 family
proteins in neutrophil biology. J Leukoc Biol 2013;94:585–594.
47. Miller MD, Krangel MS. Biology and biochemistry of the chemokines: a
family of chemotactic and inflammatory cytokines. Crit Rev Immunol
1992;12:17–46.
48. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Laichalk LL,
McGillicuddy DC, Standiford TJ. Neutralization of macrophage
inflammatory protein-2 attenuates neutrophil recruitment and
bacterial clearance in murine Klebsiella pneumonia. J Infect Dis 1996;
173:159–165.
49. Standiford TJ, Kunkel SL, Greenberger MJ, Laichalk LL, Strieter RM.
Expression and regulation of chemokines in bacterial pneumonia.
J Leukoc Biol 1996;59:24–28.
50. Brandes M, Klauschen F, Kuchen S, Germain RN. A systems analysis
identifies a feedforward inflammatory circuit leading to lethal
influenza infection. Cell 2013;154:197–212.
ORIGINAL RESEARCH
418 American Journal of Respiratory Cell and Molecular Biology Volume 55 Number 3 | September 2016
